您的位置：
首页
>
农业专利
>
详情页
Indazole inhibitors of WNT signaling pathways and therapeutic uses thereof
专利权人:
Samumed; LLC
发明人:
HOOD, John,WALLACE, David,KC, Sunil
申请号：
ES13772420
公开号：
ES2635386T3
申请日:
2013.03.13
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
A compound of the formula: ** Formula ** or a pharmaceutically acceptable salt thereof.Un compuesto de fórmula:**Fórmula** o una sal farmacéuticamente aceptable del mismo.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Compounds derived from indazol - 3 - carboxamidas, as inhibitors of the Signaling Pathway of Wnt / - catenin B； Pharmaceutical composition that comprises； and its use for the treatment of cancer, rheumatoid arthritis, viral and fungal infections, Parkinson's disease, fibrotic disorders, Among other diseases.
Modulators of antiviral signaling pathways and therapeutic uses thereof
Compounds derived from 3 - (imidazo [4,5-c] pyridin-2-yl) - indazol, inhibitors of one or more proteins in the WNT signaling Pathway； Pharmaceutical Composition and method of treatment of a disorder or disease that is involved in the Aberrant WNT signaling such as cancer, osteoartriti S and Alzheimer's disease, among others.
COMPOUNDS FOR TREATMENT OF FIBROSIS DISEASES
INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS
